Lantheus Holdings (LNTH) announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging, a subsidiary of Life Healthcare Group Holdings. As part of the acquisition, Ludger Dinkelborg, PhD, formerly CEO and Managing Director of Life Molecular Imaging (LTGHY), has been appointed Head of Research and Development at Lantheus effective August 1, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH: